-       Report 
   - June 2022
    -  38 Pages 
    Global
   
   From       €3585EUR$3,995USD£3,146GBP 
                -       Report 
   - January 2024
    -  200 Pages 
    Global
   
   From       €3724EUR$4,150USD£3,268GBP 
                -       Report 
   - March 2019
    -  372 Pages 
    Global
   
        €19741EUR$22,000USD£17,326GBP 
                     -       Book 
   - December 2018
    -  277 Pages 
    
   From       €116EUR$129USD£102GBP 
                                         
         The Arrhythmia market is a subset of the Cardiology market, focusing on the diagnosis and treatment of abnormal heart rhythms. Arrhythmias are caused by a variety of factors, including genetics, lifestyle, and underlying medical conditions. Treatment options include medications, lifestyle changes, and medical devices such as pacemakers and implantable cardioverter defibrillators (ICDs).
The Arrhythmia market is highly competitive, with a range of products and services available from a variety of    companies. These include pharmaceutical companies, medical device manufacturers, and healthcare providers. Companies in the market include Abbott, Boston Scientific, Medtronic, St. Jude Medical, and Biotronik. Show Less   Read more